Shaun Berg has worked as a lawyer in area of technology law for the last ten years. He has completed national and international transactions in the areas of biotechnology and software. His experience includes:
Commercialisation of FDA Approved Drug for Marataux Lamy Disease to US Pharmaceutical Company - market exceeding $2B.
Commercialisation of FDA Approved Drug for Hunter Disease to US Pharmaceutical Company - market exceeding $3B.
Commercialisation of new-born screening techniques to a US based institution, including consideration of IP issues, structuring of the licensing deal and supporting documentation – market exceeding $50M per year.
Management of patent portfolio for major public sector research hospital, including decisions to patent, shaping and structuring claims, prosecution and maintenance – number of patents exceeding 100.
Negotiation and Drafting of Production Investment Agreement, Completion Guarantee and other documents for the film ‘Wolf Creek’.
Commercialisation of security application with Symantec including negotiation of term sheet, licensing arrangements and associated contractual arrangements.
Shaun Berg currently teaches ‘Legal Issues in the Commercialisation of Technology’ within the Master of Science and Technology Commercialisation Program at the University of Adelaide. This course is focused upon the creation of holistic strategies for control and use of Intellectual Property including Patents, Designs, Copyright, Trademarks and Trade Secrets.